Kiniksa Pharmaceuticals International
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KNSA and other ETFs, options, and stocks.About KNSA
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
CEOSanj K. Patel
CEOSanj K. Patel
Employees315
Employees315
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2024
Founded2024
Employees315
Employees315
KNSA Key Statistics
Market cap3.17B
Market cap3.17B
Price-Earnings ratio91.50
Price-Earnings ratio91.50
Dividend yield—
Dividend yield—
Average volume742.60K
Average volume742.60K
High today$42.13
High today$42.13
Low today$35.10
Low today$35.10
Open price$40.57
Open price$40.57
Volume1.09M
Volume1.09M
52 Week high$44.42
52 Week high$44.42
52 Week low$18.12
52 Week low$18.12
Stock Snapshot
With a market cap of 3.17B, Kiniksa Pharmaceuticals International(KNSA) trades at $41.83. The stock has a price-to-earnings ratio of 91.50.
On 2026-01-22, Kiniksa Pharmaceuticals International(KNSA) stock moved within a range of $35.10 to $42.13. With shares now at $41.83, the stock is trading +19.2% above its intraday low and -0.7% below the session's peak.
Trading activity shows a volume of 1.09M, compared to an average daily volume of 742.6K.
Over the past 52 weeks, Kiniksa Pharmaceuticals International(KNSA) stock has traded between a high of $44.42 and a low of $18.12.
Over the past 52 weeks, Kiniksa Pharmaceuticals International(KNSA) stock has traded between a high of $44.42 and a low of $18.12.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own KNSA. This list is generated using Robinhood data, and it’s not a recommendation.